Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVCT

Nuvectis Pharma Inc

Dec 08 • 04:00PM ET

8.19

Dollar change -0.25
Percentage change -2.96	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.47	Insider Own	64.18%	Shs Outstand	14.64M	Perf Week	-2.62%
Market Cap	141.77M	Forward P/E	-	EPS next Y	-1.52	Insider Trans	2.05%	Shs Float	6.20M	Perf Month	-0.61%
Income	-22.33M	PEG	-	EPS next Q	-0.39	Inst Own	7.38%	Short Float / Ratio	5.57% / 7.87	Perf Quarter	-40.26%
Sales	0.00M	P/S	-	EPS this Y	5.83%	Inst Trans	29.42%	Short Interest	0.35M	Perf Half Y	-54.04%
Book/sh	0.96	P/B	8.50	EPS next Y	-7.03%	ROA	-94.78%	Target Price	20.67	Perf Year	7.20%
Cash/sh	1.27	P/C	6.43	EPS next 5Y	-	ROE	-120.53%	52W Range	7.14 - 18.65	Perf YTD	9.20%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-133.85%	52W High	-56.09%	Beta	0.19
Dividend %	-	Quick Ratio	3.99	Sales past 5Y	0.00%	Gross Margin	-	52W Low	14.71%	ATR	0.65
Employees	11	Current Ratio	3.99	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	40.77	Volatility	5.32% 7.61%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	12.69%	Profit Margin	-	Rel Volume	1.13	Prev Close	8.44
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 08 BMO	Payout	-	Avg Volume	43.90K	Price	8.19
Recom	1.00	SMA20	-0.87%	SMA50	-11.54%	SMA200	-38.16%	Volume	49,673	Change	-2.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-13-22	Initiated	Ladenburg Thalmann	Buy	$21

Nov-08-23 08:00AM	Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) -7.83%
Oct-24-23 08:00AM	Nuvectis Pharma Announces Upcoming Poster Presentation for NXP800 at the 2023 AACR Special Conference on Endometrial Cancer (GlobeNewswire)
Oct-16-23 09:35AM	Down -36.49% in 4 Weeks, Here's Why You Should You Buy the Dip in Nuvectis Pharma, Inc. (NVCT) (Zacks) +15.87%
Sep-25-23 07:30PM	Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation (GlobeNewswire)
Sep-21-23 08:00AM	Nuvectis Pharma Announces Upcoming Presentations for NXP800 and NXP900 (GlobeNewswire)
08:00AM	Loading…
Sep-12-23 08:00AM	Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial (GlobeNewswire)
Sep-06-23 08:00AM	Nuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900 (GlobeNewswire)
Sep-01-23 08:00AM	Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-17-23 08:00AM	Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma (GlobeNewswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 08:00AM	Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
07:14AM	Loading…
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research) +7.41%
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
06:51AM	Daily Vickers Top Buyers & Sellers for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
07:58AM	Daily Vickers Top Buyers & Sellers for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
07:16AM	Daily Vickers Top Buyers & Sellers for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research) +5.18%
07:23AM	Daily Vickers Top Buyers & Sellers for 07/21/2023 (Argus Research)
06:55AM	Loading…
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
06:55AM	Daily Vickers Top Buyers & Sellers for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
07:10AM	Daily Vickers Top Buyers & Sellers for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research)
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
06:50AM	Daily Vickers Top Buyers & Sellers for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
07:02AM	Daily Vickers Top Buyers & Sellers for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
06:08AM	Daily Vickers Top Buyers & Sellers for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research) +5.97%
06:56AM	Daily Vickers Top Buyers & Sellers for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 07:13AM	Daily Vickers Top Buyers & Sellers for 06/28/2023 (Argus Research)
06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research)
06:46AM	Daily Vickers Top Buyers & Sellers for 06/27/2023 (Argus Research)
Jun-26-23 06:41AM	Daily Vickers Top Buyers & Sellers for 06/26/2023 (Argus Research)
Jun-21-23 07:20AM	Daily Vickers Top Buyers & Sellers for 06/21/2023 (Argus Research)
Jun-20-23 08:00AM	Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
06:35AM	Daily Vickers Top Buyers & Sellers for 06/20/2023 (Argus Research)
Jun-18-23 08:03AM	Charles Mosseri-Marlio Buys 1.3% More Nuvectis Pharma Shares \ (Simply Wall St.)
Jun-05-23 08:50AM	Here's Why Momentum in Nuvectis Pharma, Inc. (NVCT) Should Keep going (Zacks)
Jun-01-23 04:48AM	Zacks.com featured highlights Corsair Gaming, Nuvectis Pharma and WisdomTree (Zacks)
May-31-23 06:22AM	3 Best Breakout Stocks Worth Buying for Superlative Returns (Zacks)
May-19-23 08:50AM	Here's What Could Help Nuvectis Pharma, Inc. (NVCT) Maintain Its Recent Price Strength (Zacks)
May-15-23 09:55AM	Wall Street Analysts Think Nuvectis Pharma, Inc. (NVCT) Could Surge 29.35%: Read This Before Placing a Bet (Zacks) +6.19%
08:00AM	Nuvectis Pharma Announces FDA Clearance of NXP900 IND (GlobeNewswire)
May-10-23 08:00AM	Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
May-09-23 01:34PM	We're Not Very Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Rate (Simply Wall St.)
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research) -5.07%
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research)
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 10:14AM	Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
08:00AM	Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research) -5.33%
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-18-23 08:00AM	Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800's Activity in Cholangiocarcinoma PDX Models at the 2023 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research)
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research) +9.57%
Apr-10-23 08:00AM	Nuvectis Pharma Announces Initiation of the Phase 1b Study for NXP800 in Platinum-Resistant, ARID1a-Mutated Ovarian Carcinoma (GlobeNewswire)
06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 07:19AM	Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have recently purchased stock and their bets paid off last week as company hit US$198m market cap (Simply Wall St.) -5.75%
06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research) +5.47%
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research) +5.79%
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research)
Mar-17-23 08:00AM	Nuvectis Pharma Announces Upcoming Presentations at the 2023 American Association for Cancer Research Meeting (GlobeNewswire) +5.66%
Mar-10-23 08:00AM	Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference (GlobeNewswire) +7.73%
Mar-09-23 05:29AM	Bullish insiders bet US$1.1m on Nuvectis Pharma, Inc. (NASDAQ:NVCT) (Simply Wall St.) -9.58%
Mar-07-23 08:00AM	Nuvectis Pharma, Inc. Reports Fiscal Year 2022 Financial Results and Business Highlights (GlobeNewswire)
Feb-23-23 08:00AM	Nuvectis Pharma Recaps Poster Presentation Highlights for NXP800 at the 2023 ESMO Gynecological Cancers Congress (GlobeNewswire)
Feb-16-23 07:28AM	Daily Vickers Top Insider Picks for 02/16/2023 (Argus Research)
Feb-15-23 07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research)
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research) +21.57%

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BENTSUR RON	Chairman & CEO	Oct 10	Buy	11.08	640	7,091	3,237,484	Oct 12 04:05 PM
BENTSUR RON	Chairman & CEO	Oct 09	Buy	11.19	830	9,288	3,236,844	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 06	Buy	11.27	250	2,818	3,236,014	Oct 10 08:30 AM
BENTSUR RON	Chairman & CEO	Oct 05	Buy	11.09	1,400	15,526	3,235,764	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Oct 04	Buy	10.95	1,820	19,929	3,234,364	Oct 06 08:37 AM
BENTSUR RON	Chairman & CEO	Aug 16	Buy	15.15	115	1,742	3,232,544	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 15	Buy	14.34	235	3,370	3,232,429	Aug 16 04:05 PM
BENTSUR RON	Chairman & CEO	Aug 11	Buy	14.66	180	2,639	3,232,194	Aug 11 06:07 PM
BENTSUR RON	Chairman & CEO	Aug 08	Buy	14.83	120	1,780	3,232,014	Aug 11 06:07 PM
Mosseri Marlio Charles	10% Owner	Jul 31	Buy	13.88	860	11,937	2,595,000	Aug 01 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 28	Buy	13.91	2,584	35,943	2,594,140	Jul 31 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 27	Buy	13.98	1,556	21,753	2,591,556	Jul 28 08:00 AM
Mosseri Marlio Charles	10% Owner	Jul 26	Buy	13.97	10,000	139,700	2,590,000	Jul 27 06:52 AM
Mosseri Marlio Charles	10% Owner	Jul 21	Buy	14.61	2,844	41,551	2,580,000	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 21	Buy	14.85	225	3,341	3,231,894	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 20	Buy	14.40	5,394	77,674	2,577,156	Jul 24 04:45 PM
BENTSUR RON	Chairman & CEO	Jul 20	Buy	15.06	110	1,657	3,231,669	Jul 24 04:45 PM
Mosseri Marlio Charles	10% Owner	Jul 19	Buy	14.84	8,000	118,720	2,571,762	Jul 20 06:30 AM
BENTSUR RON	Chairman & CEO	Jul 19	Buy	14.33	200	2,866	3,231,559	Jul 20 06:30 AM
Mosseri Marlio Charles	10% Owner	Jul 18	Buy	14.84	9,149	135,771	2,563,762	Jul 19 08:06 AM
BENTSUR RON	Chairman & CEO	Jul 14	Buy	15.03	150	2,254	3,231,359	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 12	Buy	15.09	3,285	49,571	2,554,613	Jul 13 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 11	Buy	15.36	10,000	153,600	2,551,328	Jul 12 08:30 AM
Mosseri Marlio Charles	10% Owner	Jul 07	Buy	15.19	8,948	135,920	2,541,328	Jul 10 08:00 AM
BENTSUR RON	Chairman & CEO	Jul 07	Buy	16.19	110	1,781	3,231,209	Jul 18 08:34 AM
Mosseri Marlio Charles	10% Owner	Jul 06	Buy	15.01	3,179	47,717	2,532,380	Jul 07 08:04 AM
BENTSUR RON	Chairman & CEO	Jul 06	Buy	14.88	320	4,762	3,231,099	Jul 07 08:03 AM
Mosseri Marlio Charles	10% Owner	Jul 05	Buy	15.52	1,176	18,252	2,529,201	Jul 06 07:45 AM
Mosseri Marlio Charles	10% Owner	Jun 26	Buy	16.46	16,760	275,870	2,528,025	Jun 27 08:45 AM
BENTSUR RON	Chairman & CEO	Jun 26	Buy	16.50	750	12,375	3,230,779	Jun 27 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 23	Buy	17.43	73,175	1,275,440	2,511,265	Jun 26 08:45 AM
Mosseri Marlio Charles	10% Owner	Jun 22	Buy	17.73	6,999	124,092	2,438,090	Jun 23 08:59 AM
Mosseri Marlio Charles	10% Owner	Jun 21	Buy	17.71	6,091	107,872	2,431,091	Jun 23 08:59 AM
BENTSUR RON	Chairman & CEO	Jun 21	Buy	17.88	500	8,940	3,230,029	Jun 22 08:42 AM
Mosseri Marlio Charles	10% Owner	Jun 16	Buy	17.75	12,700	225,425	2,425,000	Jun 20 08:25 AM
Mosseri Marlio Charles	10% Owner	Jun 15	Buy	17.71	32,124	568,848	2,412,300	Jun 16 06:46 AM
BENTSUR RON	Chairman & CEO	Jun 08	Buy	17.53	120	2,104	3,229,529	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	Jun 07	Buy	17.41	230	4,004	3,229,409	Jun 08 09:28 PM
BENTSUR RON	Chairman & CEO	May 31	Buy	17.28	330	5,702	3,229,179	Jun 01 08:00 AM
BENTSUR RON	Chairman & CEO	May 24	Buy	17.49	200	3,498	3,228,849	May 26 09:29 AM
BENTSUR RON	Chairman & CEO	May 16	Buy	17.02	320	5,448	3,228,649	May 18 07:00 AM
Poradosu Enrique	Chief Science & Business Off	Mar 27	Buy	11.55	500	5,775	1,373,819	Mar 28 08:30 AM
BENTSUR RON	Chairman & CEO	Mar 23	Buy	12.13	230	2,790	3,228,329	Mar 27 08:21 AM
BENTSUR RON	Chairman & CEO	Mar 21	Buy	12.08	480	5,798	3,228,099	Mar 23 08:30 AM
Shemesh Shay	Chief Dev. & Ops. Officer	Mar 21	Buy	11.99	420	5,036	1,361,955	Mar 22 08:30 AM
Shemesh Shay	Chief Dev. & Ops. Officer	Mar 15	Buy	10.71	670	7,176	1,361,535	Mar 17 08:31 AM
BENTSUR RON	Chairman & CEO	Mar 15	Buy	10.91	480	5,237	3,227,619	Mar 16 04:45 PM
BENTSUR RON	Chairman & CEO	Mar 14	Buy	10.85	1,680	18,228	3,227,139	Mar 16 04:45 PM
Shemesh Shay	Chief Dev. & Ops. Officer	Dec 21	Buy	7.65	500	3,825	1,245,865	Dec 22 08:30 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVCT

Nuvectis Pharma Inc

Upgrade your FINVIZ experience